Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease
You Me Sung, Taehee Lee, Hyejin Yoon, Amanda Marie DiBattista, Jung Min Song, Yoojin Sohn, Emily Isabella Moffat, R. Scott Turner, Mira Jung, Jungsu Kim, Hyang Sook Hoe
Dive into the research topics of 'Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease'. Together they form a unique fingerprint.